US Patent Issued to SURFACE OPHTHALMICS on May 27 for "Use of chondroitin sulfate for relieving ocular pain" (California, Minnesota Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,981, issued on May 27, was assigned to SURFACE OPHTHALMICS INC. (Pleasanton, Calif.).

"Use of chondroitin sulfate for relieving ocular pain" was invented by Richard L. Lindstrom (Wayzata, Minn.), Kamran Hosseini (Pleasanton, Calif.) and Lyle Bowman (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Chondroitin sulfate-based pharmaceutical formulations useful for the treatment of ocular pain or discomfort, such as occurring from ocular surgery, dry eye disease, ocular surgery induced dry eye disease, contact lens induced ocular surface dry eye disease, preservative induced ocular surface disease, conjunctivitis, corneal abrasion, burn...